H-HSITYLLPV-OH

Ref. 3D-PP47116

Produktinformation

• Name: H-HSITYLLPV-OH
• Synonyme: NH2-His-Ser-Ile-Thr-Tyr-Leu-Leu-Pro-Val-OH

Beschreibung

Peptide H-HSITYLLPV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-HSITYLLPV-OH include the following: The structural basis of HLA-associated drug hypersensitivity syndromes YA Pompeu , JD Stewart, S Mallal - Immunological , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1600-065X.2012.01163.x Abacavir forms novel cross-linking abacavir protein adducts in patients X Meng , AS Lawrenson , NG Berry - Chemical research in , 2014 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/tx400406p Molecular docking predictions of fragrance binding to human leukocyte antigen molecules RJ Schutte, X Zhang, N An , DA Ostrov - Contact , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/cod.13283 Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back R Schrijvers , L Gilissen , AM Chiriac - Clinical and translational , 2015 - Springerhttps://link.springer.com/article/10.1186/s13601-015-0073-8 HLA and pharmacogenetics of drug hypersensitivity R Pavlos , S Mallal , E Phillips - Pharmacogenomics, 2012 - Future Medicinehttps://www.futuremedicine.com/doi/abs/10.2217/pgs.12.108 Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA-B* 57: 01 binding and T-cell activation PJ Thomson, PT Illing , J Farrell, M Alhaidari, CC Bell - Allergy, 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/all.14057 Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response KD White, WH Chung, SI Hung , S Mallal - Journal of Allergy and , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0091674915008696 Adverse drug reactions triggered by the common HLA-B* 57: 01 variant: virtual screening of DrugBank using 3D molecular docking G Van Den Driessche , D Fourches - Journal of Cheminformatics, 2018 - Springerhttps://link.springer.com/article/10.1186/s13321-018-0257-z Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B:*: 57: 01-restricted CD8:+: T-cell activation DJ Naisbitt , EL Yang, M Alhaidari, NG Berry - Aids, 2015 - journals.lww.comhttps://journals.lww.com/aidsonline/fulltext/2015/11280/Towards_depersonalized_abacavir_therapy__chemical.2.aspx Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire DA Ostrov, BJ Grant , YA Pompeu - Proceedings of the , 2012 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1207934109 Structural elements recognized by abacavir-induced T cells D Yerly, YA Pompeu , RJ Schutte, KK Eriksson - International journal of , 2017 - mdpi.comhttps://www.mdpi.com/1422-0067/18/7/1464 Characterization of the MHC Peptidome and Identification of O-GlcNAcylation Sites by Mass Spectrometry AS Wriston - 2015 - libraetd.lib.virginia.eduhttps://libraetd.lib.virginia.edu/downloads/6395w7484?filename=ASW_Dissertation_Final.pdf HLAs: key regulators of T-cell-mediated drug hypersensitivity AJ Redwood , RK Pavlos , KD White, EJ Phillips - Hla, 2018 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/tan.13183 Abacavir impairs an HLA-B* 5701-restricted CD8+ T Cell response to an immunodominant Epstein-Barr virus epitope A Lucas , V Meyer-Pannwitt - 20th , 2013 - researchportal.murdoch.edu.auhttps://researchportal.murdoch.edu.au/esploro/outputs/conferencePaper/Abacavir-impairs-an-HLA-B5701-restricted-CD8-T/991005541102907891?skipUsageReporting=true&skipUsageReporting=true&recordUsage=false&recordUsage=false&institution=61MUN_INST

• Marke: Biosynth